Autologous stem cell transplantation in
β
Shaji K. Kumar; David Dingli; Martha Q. Lacy; Angela Dispenzieri; Suzanne R. Hay
π
Article
π
2008
π
John Wiley and Sons
π
English
β 112 KB
π 2 views
## Abstract Highβdose therapy and autologous stem cell transplant (HDT) have been shown to prolong survival in multiple myeloma (MM) in randomized trials, but only included patients of 65 years or younger. Given the median age at diagnosis of 66 years, it is important to have a better understanding